{"entity":{"type":"insider","cik":"0001801050","url":"/insider/0001801050","json_url":"/insider/0001801050.json","name":"Welgus Howard G.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":75,"n_filings":56,"first":"2020-08-05","last":"2026-08-19","span_basis":"filed_date"},"name_variants":[{"name":"Welgus Howard G.","source":"filing","n_filings":56,"first_seen":"2020-08-05","last_seen":"2026-08-19"}],"transactions":[{"id":9298140,"accession":"0001628280-26-058008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-058008","line_url":"/filing/0001628280-26-058008#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4730.0,"shares_display":"4,730","price_per_share":26.1807,"price_display":"26.18","price_state":"stated","total_value":123834.711,"total_display":"123,834.71","total_whole":"123,835","shares_owned_after":36475.0,"shares_owned_after_display":"36,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"insider"},{"id":6059823,"accession":"0001628280-26-048641","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-26-048641","line_url":"/filing/0001628280-26-048641#line-4","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4730.0,"shares_display":"4,730","price_per_share":26.91,"price_display":"26.91","price_state":"stated","total_value":127284.3,"total_display":"127,284.30","total_whole":"127,284","shares_owned_after":37109.0,"shares_owned_after_display":"37,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-15","filed_date":"2026-07-17","scope":"insider"},{"id":5967116,"accession":"0001628280-26-044079","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-26-044079","line_url":"/filing/0001628280-26-044079#line-5","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":635.0,"shares_display":"635","price_per_share":25.67,"price_display":"25.67","price_state":"stated","total_value":16300.45,"total_display":"16,300.45","total_whole":"16,300","shares_owned_after":37743.0,"shares_owned_after_display":"37,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-17","scope":"insider"},{"id":5967114,"accession":"0001628280-26-044079","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-26-044079","line_url":"/filing/0001628280-26-044079#line-4","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4096.0,"shares_display":"4,096","price_per_share":24.4093,"price_display":"24.41","price_state":"stated","total_value":99980.4928,"total_display":"99,980.49","total_whole":"99,980","shares_owned_after":38378.0,"shares_owned_after_display":"38,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-17","scope":"insider"},{"id":5747963,"accession":"0001801050-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001801050-26-000002","line_url":"/filing/0001801050-26-000002#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7144.0,"shares_display":"7,144","price_per_share":22.9871,"price_display":"22.99","price_state":"stated","total_value":164219.8424,"total_display":"164,219.84","total_whole":"164,220","shares_owned_after":32600.0,"shares_owned_after_display":"32,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-05","scope":"insider"},{"id":5966790,"accession":"0001628280-26-023736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-023736","line_url":"/filing/0001628280-26-023736#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":23.8801,"price_display":"23.88","price_state":"stated","total_value":238801.0,"total_display":"238,801.00","total_whole":"238,801","shares_owned_after":39744.0,"shares_owned_after_display":"39,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-03","scope":"insider"},{"id":5814271,"accession":"0001628280-26-014639","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-014639","line_url":"/filing/0001628280-26-014639#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.6518,"price_display":"25.65","price_state":"stated","total_value":256518.0,"total_display":"256,518.00","total_whole":"256,518","shares_owned_after":49744.0,"shares_owned_after_display":"49,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":6149773,"accession":"0001628280-26-005567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-005567","line_url":"/filing/0001628280-26-005567#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.0483,"price_display":"25.05","price_state":"stated","total_value":250483.0,"total_display":"250,483.00","total_whole":"250,483","shares_owned_after":59744.0,"shares_owned_after_display":"59,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":5933323,"accession":"0001628280-26-000969","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-000969","line_url":"/filing/0001628280-26-000969#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.9606,"price_display":"28.96","price_state":"stated","total_value":289606.0,"total_display":"289,606.00","total_whole":"289,606","shares_owned_after":69744.0,"shares_owned_after_display":"69,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-06","scope":"insider"},{"id":5133563,"accession":"0001801050-25-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001801050-25-000008","line_url":"/filing/0001801050-25-000008#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.2133,"price_display":"30.21","price_state":"stated","total_value":302133.0,"total_display":"302,133.00","total_whole":"302,133","shares_owned_after":79744.0,"shares_owned_after_display":"79,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-03","scope":"insider"},{"id":4360407,"accession":"0001801050-25-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001801050-25-000007","line_url":"/filing/0001801050-25-000007#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.2669,"price_display":"25.27","price_state":"stated","total_value":252669.0,"total_display":"252,669.00","total_whole":"252,669","shares_owned_after":89744.0,"shares_owned_after_display":"89,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-03","filed_date":"2025-11-05","scope":"insider"},{"id":4360404,"accession":"0001801050-25-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001801050-25-000005","line_url":"/filing/0001801050-25-000005","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.9227,"price_display":"18.92","price_state":"stated","total_value":189227.0,"total_display":"189,227.00","total_whole":"189,227","shares_owned_after":100206.0,"shares_owned_after_display":"100,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-03","scope":"insider","n_lines":2},{"id":4186438,"accession":"0001787306-25-000132","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001787306-25-000132","line_url":"/filing/0001787306-25-000132#line-2","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":15.6383,"price_display":"15.64","price_state":"stated","total_value":156383.0,"total_display":"156,383.00","total_whole":"156,383","shares_owned_after":100206.0,"shares_owned_after_display":"100,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-04","scope":"insider"},{"id":4360321,"accession":"0001787306-25-000115","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001787306-25-000115","line_url":"/filing/0001787306-25-000115","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.2982,"price_display":"14.30","price_state":"stated","total_value":142982.0,"total_display":"142,982.00","total_whole":"142,982","shares_owned_after":100206.0,"shares_owned_after_display":"100,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-01","filed_date":"2025-08-05","scope":"insider","n_lines":2},{"id":4213346,"accession":"0001787306-25-000101","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001787306-25-000101","line_url":"/filing/0001787306-25-000101#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9208.0,"shares_display":"9,208","price_per_share":13.8391,"price_display":"13.84","price_state":"stated","total_value":127430.4328,"total_display":"127,430.43","total_whole":"127,430","shares_owned_after":100206.0,"shares_owned_after_display":"100,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-01","filed_date":"2025-07-02","scope":"insider"},{"id":4155110,"accession":"0001787306-25-000099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001787306-25-000099","line_url":"/filing/0001787306-25-000099#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10139.0,"shares_display":"10,139","price_per_share":13.3715,"price_display":"13.37","price_state":"stated","total_value":135573.6385,"total_display":"135,573.64","total_whole":"135,574","shares_owned_after":109414.0,"shares_owned_after_display":"109,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-18","filed_date":"2025-06-20","scope":"insider"},{"id":4252503,"accession":"0001787306-25-000077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001787306-25-000077","line_url":"/filing/0001787306-25-000077#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.6357,"price_display":"14.64","price_state":"stated","total_value":146357.0,"total_display":"146,357.00","total_whole":"146,357","shares_owned_after":111944.0,"shares_owned_after_display":"111,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-01","filed_date":"2025-05-05","scope":"insider"},{"id":4155105,"accession":"0001787306-25-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001787306-25-000054","line_url":"/filing/0001787306-25-000054#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":15.1236,"price_display":"15.12","price_state":"stated","total_value":151236.0,"total_display":"151,236.00","total_whole":"151,236","shares_owned_after":121944.0,"shares_owned_after_display":"121,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-03","scope":"insider"},{"id":4744085,"accession":"0001787306-25-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001787306-25-000040","line_url":"/filing/0001787306-25-000040#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":13.0048,"price_display":"13.00","price_state":"stated","total_value":130048.0,"total_display":"130,048.00","total_whole":"130,048","shares_owned_after":131944.0,"shares_owned_after_display":"131,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":4744081,"accession":"0001787306-25-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001787306-25-000015","line_url":"/filing/0001787306-25-000015#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.71,"price_display":"12.71","price_state":"stated","total_value":127100.0,"total_display":"127,100.00","total_whole":"127,100","shares_owned_after":141944.0,"shares_owned_after_display":"141,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-04","scope":"insider"},{"id":4744079,"accession":"0001787306-25-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001787306-25-000002","line_url":"/filing/0001787306-25-000002#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.6714,"price_display":"14.67","price_state":"stated","total_value":146714.0,"total_display":"146,714.00","total_whole":"146,714","shares_owned_after":151944.0,"shares_owned_after_display":"151,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-06","scope":"insider"},{"id":3139667,"accession":"0001787306-24-000167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001787306-24-000167","line_url":"/filing/0001787306-24-000167#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.5133,"price_display":"12.51","price_state":"stated","total_value":125133.0,"total_display":"125,133.00","total_whole":"125,133","shares_owned_after":161944.0,"shares_owned_after_display":"161,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-03","scope":"insider"},{"id":2328514,"accession":"0001787306-24-000143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001787306-24-000143","line_url":"/filing/0001787306-24-000143#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":8.6541,"price_display":"8.65","price_state":"stated","total_value":86541.0,"total_display":"86,541.00","total_whole":"86,541","shares_owned_after":171944.0,"shares_owned_after_display":"171,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-01","filed_date":"2024-11-05","scope":"insider"},{"id":2134213,"accession":"0001787306-24-000137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001787306-24-000137","line_url":"/filing/0001787306-24-000137#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":9.2616,"price_display":"9.26","price_state":"stated","total_value":92616.0,"total_display":"92,616.00","total_whole":"92,616","shares_owned_after":181944.0,"shares_owned_after_display":"181,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-03","scope":"insider"},{"id":2295235,"accession":"0001787306-24-000131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001787306-24-000131","line_url":"/filing/0001787306-24-000131#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":10.7695,"price_display":"10.77","price_state":"stated","total_value":107695.0,"total_display":"107,695.00","total_whole":"107,695","shares_owned_after":191944.0,"shares_owned_after_display":"191,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-05","scope":"insider"},{"id":2925644,"accession":"0001787306-24-000115","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001787306-24-000115","line_url":"/filing/0001787306-24-000115","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":9.8696,"price_display":"9.87","price_state":"stated","total_value":98696.0,"total_display":"98,696.00","total_whole":"98,696","shares_owned_after":180339.0,"shares_owned_after_display":"180,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-01","filed_date":"2024-08-05","scope":"insider","n_lines":2},{"id":2134212,"accession":"0001787306-24-000108","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001787306-24-000108","line_url":"/filing/0001787306-24-000108#line-3","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":9.3141,"price_display":"9.31","price_state":"stated","total_value":93141.0,"total_display":"93,141.00","total_whole":"93,141","shares_owned_after":180339.0,"shares_owned_after_display":"180,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-02","scope":"insider"},{"id":2134208,"accession":"0001787306-24-000087","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001787306-24-000087","line_url":"/filing/0001787306-24-000087","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":8.00917036,"price_display":"8.01","price_state":"stated","total_value":80091.7036,"total_display":"80,091.70","total_whole":"80,092","shares_owned_after":170200.0,"shares_owned_after_display":"170,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-06","scope":"insider","n_lines":2},{"id":8663008,"accession":"0001787306-23-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001787306-23-000036","line_url":"/filing/0001787306-23-000036#line-2","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":13.968,"price_display":"13.97","price_state":"stated","total_value":118728.0,"total_display":"118,728.00","total_whole":"118,728","shares_owned_after":165825.0,"shares_owned_after_display":"165,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-18","scope":"insider"},{"id":7852385,"accession":"0001787306-23-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001787306-23-000027","line_url":"/filing/0001787306-23-000027#line-2","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":102085.0,"total_display":"102,085.00","total_whole":"102,085","shares_owned_after":165825.0,"shares_owned_after_display":"165,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-06","filed_date":"2023-04-10","scope":"insider"},{"id":7984891,"accession":"0001787306-23-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001787306-23-000010","line_url":"/filing/0001787306-23-000010#line-2","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":16.9826,"price_display":"16.98","price_state":"stated","total_value":144352.1,"total_display":"144,352.10","total_whole":"144,352","shares_owned_after":165825.0,"shares_owned_after_display":"165,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-15","filed_date":"2023-02-21","scope":"insider"},{"id":8345861,"accession":"0001787306-23-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001787306-23-000004","line_url":"/filing/0001787306-23-000004#line-2","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":13.7241,"price_display":"13.72","price_state":"stated","total_value":116654.85,"total_display":"116,654.85","total_whole":"116,655","shares_owned_after":165825.0,"shares_owned_after_display":"165,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-18","scope":"insider"},{"id":6312526,"accession":"0001787306-22-000075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001787306-22-000075","line_url":"/filing/0001787306-22-000075#line-2","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3403.0,"shares_display":"3,403","price_per_share":20.0125,"price_display":"20.01","price_state":"stated","total_value":68102.5375,"total_display":"68,102.54","total_whole":"68,103","shares_owned_after":165825.0,"shares_owned_after_display":"165,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-17","scope":"insider"},{"id":6906332,"accession":"0001567619-22-018322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-018322","line_url":"/filing/0001567619-22-018322#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":20.2944,"price_display":"20.29","price_state":"stated","total_value":121766.4,"total_display":"121,766.40","total_whole":"121,766","shares_owned_after":168208.0,"shares_owned_after_display":"168,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-06","scope":"insider"},{"id":6906270,"accession":"0001567619-22-016413","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-016413","line_url":"/filing/0001567619-22-016413#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":24.7981,"price_display":"24.80","price_state":"stated","total_value":148788.6,"total_display":"148,788.60","total_whole":"148,789","shares_owned_after":174208.0,"shares_owned_after_display":"174,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider"},{"id":6761740,"accession":"0001567619-22-014131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-014131","line_url":"/filing/0001567619-22-014131#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":24.3956,"price_display":"24.40","price_state":"stated","total_value":146373.6,"total_display":"146,373.60","total_whole":"146,374","shares_owned_after":180208.0,"shares_owned_after_display":"180,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-18","filed_date":"2022-07-18","scope":"insider"},{"id":6309671,"accession":"0001567619-22-012144","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-012144","line_url":"/filing/0001567619-22-012144#line-2","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":20.6154,"price_display":"20.62","price_state":"stated","total_value":51538.5,"total_display":"51,538.50","total_whole":"51,539","shares_owned_after":181896.0,"shares_owned_after_display":"181,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-02","scope":"insider"},{"id":6704709,"accession":"0001567619-22-009441","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-22-009441","line_url":"/filing/0001567619-22-009441#line-3","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":20.4448,"price_display":"20.44","price_state":"stated","total_value":51112.0,"total_display":"51,112.00","total_whole":"51,112","shares_owned_after":181896.0,"shares_owned_after_display":"181,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-03","scope":"insider"},{"id":6979175,"accession":"0001567619-22-007865","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-007865","line_url":"/filing/0001567619-22-007865#line-2","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":20.0245,"price_display":"20.02","price_state":"stated","total_value":150183.75,"total_display":"150,183.75","total_whole":"150,184","shares_owned_after":181896.0,"shares_owned_after_display":"181,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-01","filed_date":"2022-04-01","scope":"insider"},{"id":6900846,"accession":"0001567619-22-000625","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-000625","line_url":"/filing/0001567619-22-000625#line-2","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":21.2118,"price_display":"21.21","price_state":"stated","total_value":53029.5,"total_display":"53,029.50","total_whole":"53,030","shares_owned_after":181896.0,"shares_owned_after_display":"181,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-05","scope":"insider"},{"id":4710127,"accession":"0000899243-21-049728","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-049728","line_url":"/filing/0000899243-21-049728#line-2","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":20.1582,"price_display":"20.16","price_state":"stated","total_value":50395.5,"total_display":"50,395.50","total_whole":"50,396","shares_owned_after":181896.0,"shares_owned_after_display":"181,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":5157115,"accession":"0001567619-21-019290","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-019290","line_url":"/filing/0001567619-21-019290#line-2","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":21.8096,"price_display":"21.81","price_state":"stated","total_value":54524.0,"total_display":"54,524.00","total_whole":"54,524","shares_owned_after":181896.0,"shares_owned_after_display":"181,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider"},{"id":4819539,"accession":"0001567619-21-017896","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-017896","line_url":"/filing/0001567619-21-017896#line-2","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":23.8719,"price_display":"23.87","price_state":"stated","total_value":59679.75,"total_display":"59,679.75","total_whole":"59,680","shares_owned_after":181896.0,"shares_owned_after_display":"181,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-05","scope":"insider"},{"id":4906903,"accession":"0001567619-21-016752","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-21-016752","line_url":"/filing/0001567619-21-016752","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.797292,"price_display":"20.80","price_state":"stated","total_value":103986.46,"total_display":"103,986.46","total_whole":"103,986","shares_owned_after":182696.0,"shares_owned_after_display":"182,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-03","scope":"insider","n_lines":2},{"id":4389909,"accession":"0001567619-21-013033","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001567619-21-013033","line_url":"/filing/0001567619-21-013033#line-5","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801050","owner_name":"Welgus Howard G.","owner_display_name":"Welgus Howard G.","owner_url":"/insider/0001801050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1950.0,"shares_display":"1,950","price_per_share":26.0294,"price_display":"26.03","price_state":"stated","total_value":50757.33,"total_display":"50,757.33","total_whole":"50,757","shares_owned_after":182146.0,"shares_owned_after_display":"182,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-06","scope":"insider"}],"collapsed":true,"next_cursor":"2021-07-01|4389909","ledger_fault":false,"count":{"value":75,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":75,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":75},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001787306","name":"Arcutis Biotherapeutics, Inc.","url":"/issuer/0001787306","role":"Director","n_filings":56,"first_seen":"2020-08-05","last_seen":"2026-08-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001801050","retrieved_at":"2026-08-27T08:38:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}